Deudimethyltryptamine
serotonergic psychedelic
Deudimethyltryptamine (INNTooltip International Nonproprietary Name; developmental code names HLP004 and CYB004), also known as deuterated dimethyltryptamine (dDMT) or as DMT-d10, is a psychedelic drug of the tryptamine family related to dimethyltryptamine (DMT) which is under development for the treatment of generalized anxiety disorder, anxiety disorders, and depressive disorders. It is administered by inhalation or intravenous injection. The drug is a deuterated isotopologue of DMT with altered pharmacokinetics.
Interactions
Pharmacology
The pharmacodynamic profile of deudimethyltryptamine, including its interactions with serotonin receptors and its effects in animals, is similar to that of DMT. As with DMT, deudimethyltryptamine is a potent agonist of the serotonin 5-HT2A receptor and produces psychedelic-like effects in animals. However, deudimethyltryptamine, due to its deuteration, is more resistant to metabolism than DMT and shows a longer elimination half-life (by 2.5- to 2.9-fold) and slower clearance (by 38 to 55%) in animals. The brain to plasma ratio of deudimethyltryptamine was also increased (by 30%) relative to DMT, indicating slightly greater central permeability as well.
The pharmacokinetics and effects of deudimethyltryptamine in humans have been studied and compared with those of DMT. Its elimination half-life was 37 to 40 minutes and its duration was approximately 40 minutes. For comparison, the half-life of DMT in humans has been reported to be 9 to 12 minutes (range 5–19 minutes). Deudimethyltryptamine produced more robust psychedelic effects than DMT at lower concentrations. Additional details on the pharmacokinetics of deudimethyltryptamine in humans have also been reported.
“Deudimethyltryptamine” enters the record as serotonergic psychedelic. Crown Archives preserves that source wording while asking what Deudimethyltryptamine, serotonergic and psychedelic can confirm, complicate or overturn.
Why this record matters
“Deudimethyltryptamine” is worth following because a concise public description often conceals a longer documentary argument. Here, Deudimethyltryptamine, serotonergic and psychedelic provides the most credible route into that argument.
Vocabulary and entity names are the principal evidence signals here, because they determine the precision of every later search. The source revision retrieved here is dated Jul 29, 2026. The linked authority identifier is Q131152485. None of the 0 selected statements returned an explicit reference.
The absence of detail may reflect summary conventions rather than a lack of surviving documentation. The source lead contains qualifying language; that uncertainty should survive quotation, summary and reuse. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.
- Subject orientation
- Search vocabulary
- Locating named sources
The closest primary source, responsible institution and strongest cited specialist reference.
Three-step research path
- Establish the record: confirm the title “Deudimethyltryptamine”, its source revision and the description used here.
- Expand the search: follow Deudimethyltryptamine primary sources, Deudimethyltryptamine archive and Deudimethyltryptamine research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Deudimethyltryptamine”?
- Which institution is responsible for the underlying evidence?
- What terminology or title could unlock a more precise catalogue search?
Search terms from this dossier
This entry incorporates text from “Deudimethyltryptamine” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.